Clinical Scorecard: Rethinking Infection Diagnostics in Cystic Fibrosis

At a Glance

Key Highlights

• CFTR modulator therapies have transformed care but altered diagnostic needs.
• Reduced sputum production complicates traditional sputum culture diagnostics.
• New diagnostic approaches are needed for early infection detection.
• Innovative diagnostics may utilize alternative sample types like breath and blood.

Guideline-Based Recommendations

Diagnosis

• Develop new diagnostic tools that provide actionable information.

Management

• Utilize diagnostics to distinguish between active infections and chronic colonization.

Monitoring & Follow-up

• Implement faster diagnostic approaches to identify pulmonary exacerbations.

Risks

• Failure to adapt diagnostics may lead to delayed recognition of health deterioration.

Patient & Prescribing Data

Individuals with cystic fibrosis experiencing respiratory infections.

CFTR modulators improve outcomes but do not cure CF.

Clinical Best Practices

• Engage with the CF AMR Syndicate for insights on unmet diagnostic needs.
• Consider alternative sample types for more effective diagnostics.

Related Resources & Content

• CF AMR Syndicate